title: Arterial pressure allows monitoring the changes in cardiac output induced by volume expansion but not by norepinephrine.
abstract: OBJECTIVE
  To evaluate to which extent the systemic arterial pulse pressure could be used as a surrogate of cardiac output for assessing the effects of a fluid challenge and of norepinephrine.
  
  
  METHODS
  Observational study.
  
  
  METHODS
  Medical intensive care unit.
  
  
  METHODS
  Patients with an acute circulatory failure who received a fluid challenge (228 patients, group 1) or in whom norepinephrine was introduced or increased (145 patients, group 2).
  
  
  METHODS
  We measured the systolic, diastolic, and mean arterial pressure, pulse pressure, and the transpulmonary thermodilution cardiac output before and after the therapeutic interventions.
  
  
  RESULTS
  In group 1, the fluid challenge significantly increased cardiac output by 24% ± 25%. It significantly increased cardiac output by ≥15% (+35% ± 27%) in 142 patients ("responders"). The fluid-induced changes in cardiac output were correlated with the changes in pulse pressure (r = .56, p < .0001), systolic arterial pressure (r = .55, p < .0001), diastolic arterial pressure (r = .37, p < .0001), and mean arterial pressure (r = .52, p < .0001). At multivariate analysis, changes in pulse pressure were significantly related to changes in stroke volume (multiple r = .52) and to age (r = .12). A fluid-induced increase in pulse pressure of ≥17% allowed detecting a fluid-induced increase in cardiac output of ≥15% with a sensitivity of 65[56-72]% and a specificity of 85[76-92]%. The area under the receiver operating characteristic curves for the fluid-induced changes in mean arterial pressure and in diastolic arterial pressure was significantly lower than for pulse pressure. In group 2, the introduction/increase of norepinephrine significantly increased cardiac output by 14% ± 18%. The changes in cardiac output induced by the introduction/increase in the dose of norepinephrine were correlated with the changes in pulse pressure and systolic arterial pressure (r = .21 and .29, respectively, p = .001) but to a significantly lesser extent than in group 1.
  
  
  CONCLUSIONS
  Pulse pressure and systolic arterial pressure could be used for detecting the fluid-induced changes in cardiac output, in spite of a significant proportion of false-negative cases. By contrast, the changes in pulse pressure and systolic arterial pressure were unable to detect the changes in cardiac output induced by norepinephrine.
authors.affiliation: Service de Réanimation médicale, Hôpital de Bicêtre, AP-HP, Le Kremlin-Bicêtre, France. xavier.monnet@bct.aphp.fr
authors.forename: Xavier
authors.initials: X
authors.lastname: Monnet
authors.forename: Alexia
authors.initials: A
authors.lastname: Letierce
authors.forename: Olfa
authors.initials: O
authors.lastname: Hamzaoui
authors.forename: Denis
authors.initials: D
authors.lastname: Chemla
authors.forename: Nadia
authors.initials: N
authors.lastname: Anguel
authors.forename: David
authors.initials: D
authors.lastname: Osman
authors.forename: Christian
authors.initials: C
authors.lastname: Richard
authors.forename: Jean-Louis
authors.initials: JL
authors.lastname: Teboul
mesh_terms: D000328:Adult; D000368:Aged; D001794:Blood Pressure / Q000502:physiology*; D002302:Cardiac Output / Q000502:physiology*; D015331:Cohort Studies; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D009638:Norepinephrine / Q000627:therapeutic use*; D017063:Outcome Assessment, Health Care; D011237:Predictive Value of Tests; D012769:Shock / Q000175:diagnosis / Q000503:physiopathology* / Q000628:therapy*; D014662:Vasoconstrictor Agents / Q000627:therapeutic use*
chemical_list: D014662:Vasoconstrictor Agents; D009638:Norepinephrine